Ron Grey

Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase

Ron Grey, Albert C. Pierce, Guy W. Bemis et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)

Jon H. Come, Philip N. Collier, James A. Henderson et al. · Journal of Medicinal Chemistry · 2018 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia

Robert J.O. Davies, Albert C. Pierce, Cornelia J. Forster et al. · Journal of Medicinal Chemistry · 2011 · 20 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

VX-322: A Novel Dual Receptor Tyrosine Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia

David K. Heidary, George Q. Huang, Diane M. Boucher et al. · Journal of Medicinal Chemistry · 2012 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Interference-free determination of selenium in the presence of iron using a graphite furnace with carbon monoxide-platinum modification

Robert Peile, Ron Grey, Rodger Starek · Journal of Analytical Atomic Spectrometry · 1989 · 13 citations

Natural Sciences, Chemistry, Analytical Chemistry +13